Bicara Therapeutics Inc. Common Stock

BCAX | NASDAQ

$22.01

-$0.63 (-2.78%)

At close: Sep 21, 2026, 4:00 PM ET

$22.01

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022
PE Ratio	-6.68	-13.94	-23.41	-32.07
PEG Ratio	-0.07	-0.56	-0.63	n/a
PS Ratio	n/a	n/a	n/a	n/a
PB Ratio	2.29	1.93	5.55	-70.13
P/FCF Ratio	-8.59	-12.67	-26.22	-37.55
P/OCF Ratio	-8.61	-12.68	-26.56	-37.78
OCF/S Ratio	n/a	n/a	n/a	n/a
Debt / Equity Ratio	0	0	0	n/a
Quick Ratio	14.58	27.93	15.32	0.21
Current Ratio	14.58	27.93	15.32	0.21
Asset Turnover	n/a	n/a	n/a	n/a
Interest Coverage	n/a	n/a	n/a	-336.21
Return on Equity	-34.36%	-13.82%	-23.79%	219.04%
Return on Assets	-32.01%	-11.95%	-22.22%	-564.60%
Return on Invested Capital	-38.60%	-14.93%	-18.20%	219.02%
Dividend Yield	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a	n/a
Net Profit Margin	n/a	n/a	n/a	n/a
Pretax Profit Margin	n/a	n/a	n/a	n/a
Operating Profit Margin	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a	n/a